Eli Lilly and Company (LLY) vs Platinum Futures (PLATINUM)
See how Eli Lilly and Company and Platinum Futures differ across market data and performance, so you can decide which asset best fits your strategy.
$1,179.11
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
Platinum Futures represent standardized exchange-traded contracts linked to the future price of platinum. They are used by producers, consumers, traders, and investors to hedge exposure, express views on supply and demand, or gain commodity-market exposure. Their price is influenced by auto-catalyst demand, jewelry demand, industrial use, mine supply, investor flows, and the U.S. dollar.